500 women with advanced uterine cancer to have tumors genetically profiled

NCT ID NCT07041606

Recruiting now Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 4 times

Summary

This study looks at the genetic makeup of advanced endometrial cancer in 500 women in Russia. Researchers will test tumor samples for specific gene changes to see how common they are and what treatments patients receive. The goal is to gather information, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endometrial cancer endometrium neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ENDOMETRIAL CANCER

Contacts and locations

Locations

Research Site
RECRUITING

Arkhangelsk, Russia
Research Site
RECRUITING

Barnaul, Russia
Research Site
RECRUITING

Chelyabinsk, Russia
Research Site
RECRUITING

Irkutsk, Russia
Research Site
RECRUITING

Izhevsk, Russia
Research Site
RECRUITING

Krasnodar, Russia
Research Site
RECRUITING

Krasnoyarsk, Russia
Research Site
RECRUITING

Moscow, Russia
Research Site
RECRUITING

Murmansk, Russia
Research Site
NOT_YET_RECRUITING

Obninsk, Russia
Research Site
RECRUITING

Saint Petersburg, Russia
Research Site
NOT_YET_RECRUITING

Severodvinsk, Russia
Research Site
RECRUITING

Sochi, Russia
Research Site
RECRUITING

Tomsk, Russia
Research Site
RECRUITING

Tver', Russia
Research Site
RECRUITING

Ufa, Russia
Research Site
WITHDRAWN

Vladivostok, Russia
Research Site
RECRUITING

Yaroslavl, Russia
Research Site
RECRUITING

Yekaterinburg, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.